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ABSTRACT: This paper examines the pressure effect on the
crystallization rate of the pharmaceutically active enantiomerically
pure S-enantiomer and the racemic mixture of the well-known drug
ibuprofen. Performed experimental studies revealed that at ambient
pressure S-ibuprofen crystallizes faster than the racemic mixture.
When the pressure increases, the crystallization rate slows down for
both systems, but interestingly it is more apparent in the case of the
S-enantiomer. It is found that this experimentally observed trend
can be understood based on the predictions of the classical
nucleation theory. We suggest that the solid−liquid interfacial free
energy is the main reason for the observed variations in S- and RS-ibuprofen’s stability behaviors. Employing a special method of
computational studies, i.e., the capillary fluctuation method, we show that the increase in pressure affects the solid−liquid interfacial
free energy for S- and RS-ibuprofen in an entirely different way. Importantly, the detected differences correspond to the
experimentally observed variations in the overall crystallization rates.
■ INTRODUCTION
Through the last few decades, the rising interest in
pharmaceuticals prepared in the amorphous state has been
observed. It is mainly due to the higher dissolving rate of this
physical form in contrast to the typical crystalline phase, which
translates into the higher bioavailability of the amorphous
drug.1−3 However, all merits of the amorphous pharmaceutical
may be lost during its storage because the sample might
crystallize. Since the amorphous state is thermodynamically
unstable, it implies a possible rapid transformation of the
system to the crystalline form, which is thermodynamically
stable. Therefore, the effective preparation of the amorphous
drugs would be possible only when such undesired events are
limited.
The first and necessary step in this challenging task is a
detailed understanding of the crystallization process. One of
the most popular and widely used ways to describe the
crystallization process is the classical nucleation theory (CNT),
of which a remarkable advantage is simplicity.4−6 According to
this concept, the crystallization process is divided into two
steps, i.e., nucleation and crystal growth. The first is
characterized by the nucleation rate,7,8 N, which parametrizes
the number of crystalline nuclei created within a given space
and time. Subsequently, the formed nucleus which has reached
a certain critical size grows. The crystal growth rate, U,
describes the velocity of the increase of the crystal order within
the liquid. N and U are two separate processes, but they
actually depend on the same physical properties: systems’
dynamics, i.e., the diffusivity of the molecules at liquid phase,
D, and thermodynamic features characterized by the driving
force for the crystallization ΔG, which is the difference
between the Gibbs free energy of liquid and crystal.9−12 The
above physical quantities are easily experimentally obtained.
However, according to the CNT, the nucleation strongly
depends on the solid−liquid interfacial free energy, γ, which is
the reversible work required to create a unit area of the
interface.13 γ can be uniquely defined if the interface between
the two phases is planar and the chemical potentials of the
above phases are identical. These conditions are fulfilled for
the liquid−vapor interface at equilibrium for which extensive
experimental examinations have been performed.14−16 How-
ever, for solid−liquid interfaces, the plane of the interface
depends on the crystallographic orientation.17,18 The latter
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implies that, in general, γ is an anisotropic quantity, and
therefore its direct experimental examination is a challenging
task.18,19
The fact that γ depends on the crystal morphology20 also has
important consequences for preparing the amorphous drugs.
Considering the pharmaceuticals’ stability behavior, one
should take into account that those materials frequently
occur in various enantiomeric forms, which crystallize to the
different primitive cells. Hence, the almost identical molecules
of two enantiomers might exhibit various crystallization
tendencies.21 Interestingly, the dynamics of the enantiomeric
systems does not strongly differ, and therefore their effect on
the crystallization process might be excluded.22 Consequently,
enantiomers and their mixture seem to be interesting
candidates to examine the role of thermodynamics on the
crystallization process. One of the popular and commonly used
examples of a pharmaceutical existing in two enantiomeric
forms is ibuprofen. Conveniently, it is produced as a racemic
mixture, whereas only the S-enantiomer is therapeutically
effective. Importantly, the crystal structures of separated
enantiomers and their racemic mixture differ.23 Hence, one
might expect differences in their γ and ΔG values, which would
lead to various stability behaviors.
Taking the above into account, in this paper, we examined
the crystallization tendency for the S-enantiomer of ibuprofen
((S)-(+)-2-[4-isobutylphenyl] propionic acid) and its racemic
mixture ((2RS)-2-[4-(2-methylpropyl) phenyl] propanoic
acid). Experimental studies enabled a detailed comparison of
the overall crystallization rates for two studied materials, at
ambient and elevated pressures. Subsequently, we used the
CNT to disclose the reason for the observed differences. Our
theoretical analysis and computational calculations of the
interfacial free energy revealed that during the increase in the
pressure, the solid−liquid interfacial free energy at melting
conditions for RS-ibuprofen decreases, whereas for S-
ibuprofen, it increases. Interestingly, the effect of the
compression on ΔG is similar for both examined materials.
Consequently, our findings suggest that the thermodynamic
aspects of the crystallization process are prominently sensitive
for a final crystal structure which is formed as well as,
hypothetically, on the composition of the liquid sample.
■ EXPERIMENTAL SECTION
Materials. Ibuprofen (being a racemic mixture of (S)-ibuprofen
and (R)-ibuprofen and is labeled as RS-ibuprofen in the context) of a
purity greater than 98% was purchased from Hubei Biocause
Pharmaceutical Co. Ltd., while (S)-ibuprofen (labeled as S-ibuprofen
in the context) of 99% purity was purchased from Merck. For details
on chemical structures of the R and S enantiomers, readers can refer
to the earlier literature.24 The samples were used without further
purification.
Methods. Standard Differential Scanning Calorimetry (DSC)
Measurements. Thermodynamic properties of the tested materials
were investigated by using a Mettler-Toledo DSC apparatus equipped
with a liquid nitrogen cooling accessory and an HSS8 ceramic sensor
(a heat flux sensor with 120 thermocouples). Indium and zinc
standards were used for the temperature and enthalpy calibrations.
Samples with a mass of about 15 mg were placed in aluminum
crucibles and sealed. Experiments were performed within temperature
ranges of 200−363 K and 200−343 K for RS-ibuprofen and S-
ibuprofen, respectively, with fixed heating/cooling rates of 10 K/min
used during the heating−cooling-reheating cycles. At least three DSC
runs following the same protocol were performed for the studied
samples to ensure data reproducibility. To be consistent with the
literature results,25 in this work the melting point, Tm, is also
determined as the onset temperature.
Temperature-Modulated Differential Scanning Calorimetry
(TMDSC) Measurements. In order to study the heat capacity changes,
ΔCp, of the tested samples in the glass transition region, we applied
the stochastic temperature−modulated differential scanning calorim-
etry (TMDSC) technique implemented by Mettler-Toledo TOPEM.
The quenched S-ibuprofen and RS-ibuprofen samples were measured
in the same temperature region of 200−267 K at a heating rate of 1
K/min. In the experiments, a temperature amplitude of 0.5 K for the
pulses was selected at a switching time range with minimum and
maximum values of 15 and 30 s, respectively. As a result, we can
obtain the heat capacity Cp curves, from which the glass transition
temperature, Tg (namely, the point corresponding to the midpoint
inflection of the extrapolated onset and end of the Cp curve) as well as
the ΔCp value at this temperature can be determined.
Broadband Dielectric Spectroscopy. Dielectric measurements at
ambient pressure were performed in the frequency range of 10−2 to
106 Hz using a Novocontrol Alpha analyzer. The Quattro system
together with a nitrogen gas cryostat was employed to control the
temperature, which ensures a temperature stability within ±0.1 K.
The investigated materials were placed in between two stainless steel
electrodes (20 mm diameter) with a gap generated by using the
Kapton spacer of ∼0.05 mm thickness. As an initial step, S- and RS-
ibuprofen were, respectively, kept at temperatures of T = 343 K and T
= 363 K for 15 min to ensure the complete melting. Subsequently, the
samples were cooled to 203 K to enter the glassy states at a rate of
∼10 K/min. After this, the dielectric responses in the representations
of the real (ε′) and imaginary (ε″) parts of complex permittivity (ε*)
were recorded upon slowly heating the amorphous samples (0.5 K/
min) to high temperatures. Besides the non-isothermal studies, the
dielectric technique was used to perform the isothermal crystallization
studies. Noted is that the samples were heated up to the desired
crystallization temperature in the supercooled liquid state immediately
after achieving the glassy state at T = 203 K via rapid quenching. In
addition, to avoid the possible degradation of the tested chemicals, a
new sample was prepared for each crystallization experiment.
In the case of pressure-dependent dielectric studies, a high-pressure
system built by Unipress (Institute of High-Pressure Physics, Warsaw,
Poland) was used. The high-pressure setup consists of an MP5
micropump, an MVX-30 vessel, and a control unit, which allows
regulation of the pressure within a precision of 1 MPa. The pressure
was exerted by using silicon oil transmitted to the pressure chamber
through a system of capillary tubes (Novo Swiss). The temperature
inside the pressure vessel was controlled using a highly dynamic
temperature control system (Presto W85, Julabo). Dielectric
measurements were carried out with a capacitor of the same geometry
as that used for ambient pressure measurements (diameter 20 mm,
gap 0.05 mm, Kapton spacer). Prior to the experiments, the capacitor
was sealed with Teflon tape and then placed inside the pressure
chamber filled with pressure transmitting silicon oil. In this work,
molecular dynamics of S-ibuprofen were investigated in both
isothermal and isobaric experiments. Moreover, crystallization kinetics
of S-ibuprofen and RS-ibuprofen was compared under both ambient
and elevated pressures. In each crystallization experiment, after
completing the liquid-crystal transformation, the temperature was
increased slowly (0.5 K/min) to melt the samples, and the melting
points of the studied samples were determined from the temperature-
dependent ε′ evolutions.
Molecular Dynamics Simulation. The standard molecular
dynamics simulations have been carried out using the GROMACS
software26−29 at conditions of the constant temperature and pressure
provided by the Nose-Hoover thermostat30,31 and the Martyna−
Tuckerman−Tobias−Klein barostat.32,33 The interactions between
nonbonded and bonded atoms are defined by the OPLSAA force
field.34 The nonbonded interactions are cutoff at a distance equal to 1
nm, whereas the used time step equals 0.001 ps. The crystal structures
for S- and RS-ibuprofen were constructed according refs 35 and 36,
respectively. The crystal and liquid simulation boxes, which consist of
2302 molecules for the S-enantiomer and 2304 molecules for the
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racemic mixture, were heated or cooled from experimentally
determined melting temperatures up to a temperature higher or
lower for at least 120 K. The difference in the temperature between
subsequent simulation runs was equal to 10 K. Each simulation run
lasts for 1.5 ns during which the first 0.5 ns was dedicated for the
equilibration of the system, whereas the collected data during the last
1.0 ns were used to estimate the crystal and liquid densities,
enthalpies, and diffusion constant for the liquid phase. The latter have
been done on the basis of the mean-square displacement using the
GROMACS software.
■ RESULTS
The thermal behaviors of S-ibuprofen and RS-ibuprofen were
investigated using the standard DSC and TMDSC techniques.
In Figure 1a, for both studied materials, we can observe
pronounced endothermic peaks signifying the melting
processes. The melting points, Tm’s, were determined as 325
and 348 K, respectively, for S-ibuprofen and RS-ibuprofen.
Noteworthily, Rietveld et al. reviewed numerous studies and
reported that the melting points of S-ibuprofen and RS-
ibuprofen have averages of 323 ± 4 K and 349 ± 2 K,
respectively.37 Thus, the melting temperatures determined in
this work agree well with the literature data. To ensure the
complete melting of the samples, S-ibuprofen and RS-
ibuprofen were, respectively, kept at T = 343 K and T = 363
K for 5 min. Then, the samples were quenched to 200 K at a
rate of 10 K/min to enter their glassy states. In Figure 1b, DSC
thermograms recorded upon heating the glassy samples at 10
K/min are revealed. We can see that the glass transition
phenomena of both samples occurred in the same temperature
region. Upon further heating to temperatures above T = 300 K,
an exothermic peak (cold crystallization) immediately followed
by an endothermic peak (melting process) is observed for RS-
ibuprofen. Nevertheless, such peaks are not visible for S-
ibuprofen. As a next step, we used TMDSC to study the heat
capacity Cp changes of both samples within the glass transition
region. Immediately after the melted samples were quenched
to enter the glassy states, the temperature was slowly increased
(1 K/min) from 200 to 267 K. On the basis of the Cp curves
ascertained upon heating the samples (as seen in Figure 1c),
we can determine approximately the same Tg and ΔCp values,
which are 227.6 K and 0.417 J·g−1·K−1 for S-ibuprofen and
227.9 K and 0.404 J·g−1·K−1 for RS-ibuprofen. The
thermodynamic parameters, namely, Tg, ΔCp and Tm, are
compiled in Table 1.
As a matter of fact, we also performed dielectric studies on
the glass transition behaviors of S-ibuprofen under both
ambient and elevated pressures (see Figures S1). When
comparing the ascertained results to the data for RS-ibuprofen
as reported in our previous work,38 we noticed the identical
glass transition dynamics for S-ibuprofen and RS-ibuprofen
(see Figure S2) at various pressure conditions. Nonetheless, it
is of interest to make clear whether the crystallization kinetics
of these two materials will be different under both ambient and
elevated pressures. Hence, we applied the dielectric technique
to perform the isothermal crystallization measurements for S-
ibuprofen and RS-ibuprofen under two kinds of conditions,
namely, p = 0.1 MPa, T = 263.6 K and p = 200 MPa, T = 307
K, where the tested samples exhibit the same molecular
mobility. As demonstrated in each panel of Figure 2, the initial
dielectric loss ε″ spectra are characterized by the structural α-
relaxation peaks located at the same frequency (∼5.5 × 104
Hz). Time evolutions of the dielectric ε″ and ε′ spectra are
compiled in Figures 2 and 3, respectively. The kinks, which
might be observed in Figure 2a,b, are the experimental
artifacts, resulting probably due to the complexity of a
performed high-pressure experiment. As crystallization pro-
ceeds, the α-peak in each panel of Figure 2 shows a gradually
decreased intensity that ultimately disappears. In the case of
the dielectric ε′ spectra (see Figure 3a−d), the crystallization
phenomenon is reflected by the decreased static permittivity εs.
At the ultimate stage of crystallization, εs ceases to change with
time. For analyzing the crystallization process, we used a
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where ε′(0) and ε′(∞) are the values of static permittivity at
the initial and ultimate stages of crystallization, and ε′(t) is the
value at time t. In Figure 3e, we prepared plots of εN′ versus the
natural logarithm of time ln(t) for the tested four samples.
Moreover, in Figure 3f, the first derivative of εN′ against the
natural logarithm of time (dεN′ /d ln(t)) is plotted as functions
of ln t in terms of the so-called Avramov approach. From each
Figure 1. DSC traces for S-ibuprofen and RS-ibuprofen were recorded
upon heating (10 K/min) the samples in the crystalline (a) and glassy
(b) states. Panel (c): Heat capacity Cp curves for both chemicals
obtained within the TOPEM measurements. The temperature range
is from 200 to 267 K, and the heating rate is 1 K/min.
Table 1. Glass Transition and Melting Parameters Determined for RS-Ibuprofen and S-Ibuprofen at Ambient Pressure by
Using the Techniques of Differential Scanning Calorimetry (DSC) and Dielectric Spectroscopy (DS) and Melting Point Data
Obtained at a High Pressure of 200 MPa by Using the DS
DSC DS
materials Tg (K) ΔCp (J·g−1·K−1) Tm (K) Tg, p = 0.1 MPa (K) m, p = 0.1 MPa Tm, p = 0.1 MPa (K) Tm, p = 200 MPa (K)
RS-ibuprofen 227.9 0.404 348 224 87 345 399.1
S-ibuprofen 227.6 0.417 325 225 82.2 321.5 374.5
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dεN′ /d ln(t) - ln(t) relation in Figure 3f, we can determine a
critical parameter (τcr), which represents the characteristic time
for the overall crystallization process. For S-ibuprofen and RS-
ibuprofen samples held at p = 0.1 MPa, T = 263.6 K, the τcr
values are 307 and 380 min, respectively. When the
measurements were carried out at p = 200 MPa, T = 307 K,
the τcr values for S-ibuprofen and RS-ibuprofen are 532 and
725 min, respectively. Apparently, both S-ibuprofen and RS-
ibuprofen exhibit slower crystallization kinetics at high pressure
with respect to the ambient pressure conditions. A similar
phenomenon that pressure can suppress the crystallization has
also been observed for R,S-racemic mixture of ketoprofen.39
Additionally, as compared to RS-ibuprofen, faster crystalliza-
tion occurred for S-ibuprofen under both ambient and elevated
pressures.
As a next step, immediately after the isothermal crystal-
lization measurements, the samples were heated up slowly with
0.5 K/min for the determination of melting points under the
experimental conditions. Figure 4 depicts the temperature
dependences of ε′ recorded at a fixed frequency of 10 kHz
upon heating the studied crystalline S-ibuprofen and RS-
ibuprofen samples. In each curve, the melting process is
displayed as the step increase of ε′, and the onset temperature
is defined as the melting point. As we see, for S-ibuprofen and
RS-ibuprofen, Tm values are, respectively, 321.5 and 345 K at p
= 0.1 MPa and 374.5 and 399.1 K at p = 200 MPa. The results
at ambient pressure are in good agreement with the
aforementioned DSC results (see Table 1). In addition, the
same Tm value of 345 K has also been reported by Braś et al. in
the dielectric studies of RS-ibuprofen at ambient pressure.25
In order to gain a more thorough picture of crystallization
kinetics of S- and RS-ibuprofen, we conducted isothermal
measurements for each chemical at various temperatures under
ambient pressure. Figure 5a,b depict the corresponding εN′−T
relations ascertained for RS-ibuprofen and S-ibuprofen,
respectively. In order to analyze the data, we applied the
Avrami equation, which can be expressed as follows,40
Figure 2. Time evolutions of the dielectric loss ε″ spectra for RS-
ibuprofen (a and b) and S-ibuprofen (c and d) during the isothermal
crystallization measurements. Panels (a) and (c) show the results for
RS-ibuprofen and S-ibuprofen recorded under the same conditions of
p = 0.1 MPa and T = 263.6 K, respectively. Panels (b) and (d) depict
the results for RS-ibuprofen and S-ibuprofen recorded under the same
condition of p = 200 MPa and T = 307 K, respectively. In each panel,
spectra obtained at the beginning and end of the crystallization
process are marked.
Figure 3. Time evolutions of the dielectric ε′ spectra for RS-ibuprofen (a and b) and S-ibuprofen (c and d) during the isothermal crystallization
measurements. Results obtained for RS-ibuprofen and S-ibuprofen under the same condition of p = 0.1 MPa, T = 263.6 K are depicted in panels (a)
and (c), respectively. Panels (b) and (d) show the results for RS-ibuprofen and S-ibuprofen recorded under the same conditions of p = 200 MPa, T
= 307 K. Panel (e): relations of εN′−ln t for the tested S-ibuprofen and RS-ibuprofen samples. The results are ascertained at a fixed frequency of
11 952 Hz. Panel (f): time dependences of the first derivative of εN′ against the natural logarithm of time (dεN′ /d ln t) in terms of the Avramov
approach.
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where k and n are the overall crystallization rate constant and
Avrami exponent, respectively. t0 denotes the incubation time,
which represents a time required to produce crystal nuclei of
sufficient size for further growth. To avoid crowding, only the
exemplified fitting results at selected temperatures are shown in
Figure 5a,b. As a next step, we prepared the plots of
determined k and n values as functions of the degree of
supercooling (ΔT = Tm − T). Here, the Tm values of 348 K for
RS-ibuprofen and 325 K for S-ibuprofen were used. In Figure
5c, arch-shaped k−ΔT correlations are observed for both
tested materials. The maximum crystallization rate of S-
ibuprofen occurs at ΔT ≈ 15 K while that of RS-ibuprofen
occurs at ΔT ≈ 29 K. Slower crystallization kinetics for RS-
ibuprofen than S-ibuprofen is noticed at the same ΔT below
32 K. Nonetheless, the crystallization rate of RS-ibuprofen
slightly exceeds that of S-ibuprofen at the same ΔT above 32
K. In Figure 5d, the evolutions of the Avrami exponent n along
with the temperature are shown. For both samples, a gradually
decreasing trend of n with increasing ΔT is noticed, and n
values between 2 and 3 indicate a thermal nucleation followed
by two-dimensional crystal growth.41
■ DISCUSSION
The determination of the reasons that S-ibuprofen crystallizes
faster than the racemic mixture can be made if one employs the
theoretical description of the considered process. As we have
already mentioned, the most popular approach for a
description of the crystallization process is the CNT.
According to this concept, in the most basic and theoretically
fundamental case, i.e., for three-dimensional crystal growth, the
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where AN(T) is a kinetic prefactor, while ΔG* is the nucleation
barrier. The kinetic prefactor can be rewritten as AN(T) = 24
ZρlDn
2/3/λ2, where the Zeldovich parameter Z = (ΔGv/
6πkBTnρc)
1/2, the number of molecules in the critical nucleus n
= (4/3)(πr3ρc) of the radius r = 2γ/ΔGv, the atomic jump
distance λ = (1/ρl)
1/3, whereas ρl and ρc are the number
density of liquid and crystal, respectively. ΔGv is the driving
force per volume unit which can be obtained from ΔG and ρc.
The next physical quantity influencing the overall crystal-
lization is the crystal growth, the role of which can be
computed by the following expression
U A T f T
G
k T
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where AG(T) ≈ Dρc−1/3ρl2/3 and describes the molecular
mobility, whereas f(T) parametrizes the growth mechanism. As
it was suggested for other real material, the normal growth
model, which assumes that f is constant and equal to 1, exhibits
the best accuracy with the experimental results so far.42 As a
consequence, to use eqs 4 and 5, knowledge of the temperature
dependence of volume for liquid and crystal phases, D(T),
ΔG(T), as well as γ(T) is required. The values of the first three
quantities can be obtained from the standard experiments.
However, the direct experimental measure of γ is a challenging
task even for pure material.19,43,44 Moreover, the experimen-
Figure 4. Temperature dependences of ε′ were recorded at a fixed
frequency of 10 kHz upon heating the studied S-ibuprofen and RS-
ibuprofen samples after crystallization measurements were completed
at pressures of 0.1 and 200 MPa. The melting points as determined by
the onset temperatures of the step increases of ε′ are given.
Figure 5. Relations of εN′−T ascertained from isothermal crystal-
lization measurements for RS-ibuprofen (a) and S-ibuprofen (b) at
various temperatures under ambient pressure. Red solid lines
represent the fitting results in terms of the Avrami equation. For
both tested samples, evolutions of the obtained kinetic parameters k
(c) and n (d) along with the degree of supercooling are shown. In
panels (c) and (d), the right-half and bottom-half filled symbols
represent k and n values for both tested samples, which were
measured using the high-pressure setup under the ambient pressure
(as shown in Figures 2 and 3). In panel (c), solid lines represent the
fits to the experimental data with the use of an exponential function
plus a linear term, and the dashed vertical lines reveal the positions of
the maximum crystallization rates. In panel (d), red dashed lines
exhibit the evolution tendency of the n values.
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tally obtained values strongly depend on the used technique.
Fortunately, the alternative ways to calculate the value of γ are
derived by the computational experiments. Recently, two main
approaches have been suggested: the cleaving potential
method45−47 and the capillary fluctuation method.17,48−51 In
the cleaving potential method, the biphasic solid−liquid system
is transformed into two separate systems (liquid and solid) by
use of the external potentials. Then measurement of the work
made by those potentials during the transformation process
enables estimation of γ. It should be mentioned that precise
application of this method requires precise control of the
transformation process to ensure its reversibly, which implies
some technical difficulties.52 The employment of capillary
fluctuation method (CFM) can be done in a more direct way
because it requires only one simulation of a biphasic system
during which the fluctuations of the interfaces are measured.
The parametrized stiffness of the interface can be related to the
γ. Briefly speaking, the cleaving method is considered as one of
more precision, whereas the CFM is characterized by higher
sensitivity to the anisotropy in γ. The discussed methods have
been used to estimate γ values for model systems such as hard-
spheres46,53 and Lennard-Jones.47,50,54 However, for realistic
systems, the CFM is more often employed, which is probably
because CFM requires only one simulation run, and any
knowledge of the complex process of creating interface from
separated bulk systems is not needed. Consequently, using the
CFM, the γ values can be estimated for metallic com-
pounds,17,18,48,49 alloys,55,56 and few molecular systems57
including pharmaceuticals.20,58 Hence, we decided to apply
this method for studying the differences in γ, nucleation rate,
and an overall crystallization tendency between the S-
enantiomer and the racemic mixture of ibuprofen.
At this point, it has to be noted that CFM (as well as
cleaving potential method) can be applied only at the melting
conditions, i.e., at the conditions at which the crystal and liquid
coexist. Thus, we need to confirm that the experimentally
determined Tm is valid also for simulated systems. The latter
can be done by the examination of the biphasic system
stability. In this order, we equilibrated the crystal structure at
Tm and subsequently melted it at a sufficiently high
temperature. During this step, the conditions of constant
temperature and volume (NVT) were kept. This procedure
enables us to obtain the identical boxes filled by the crystal and
liquid. However, to ensure the identical pressure conditions,
the liquid box was elongated providing the density equal to the
liquid density at the studied melting conditions estimated from
the independent simulation run. Subsequently, the liquid
system was simulated at NVT conditions in order to fill the
box completely. In the described way, the crystal box and the
elongated box possessed an identical plane, which enabled its
joint (the small gap between boxes has been ensured to
provide the overlapping of the atoms belonging to different
phases). During the NPT simulation, which last for 10 ns, any
melting or crystallization event has not been observed,
confirming the utility of experimentally determined melting
temperatures for further computational experiments including
one determining the IFE by CFM. The final configuration of
the simulated biphasic system consisting of RS-ibuprofen
molecules is presented in Supporting Information (Figure S3).
At this point, it must be noted that the use of CFM requires
construction of the quasi-one-dimensional interfaces. There-
fore, to ensure the required geometrical condition, a special
biphasic simulation box must be created; i.e., when created
interface is parallel to the length of the system, Lx, its thickness
must be much smaller than its width, Lz ≪ Ly. The snapshot of
the simulation box created in the described way is presented in
Figure 6a. At this point, it must be noted that application of the
periodic boundary to the simulation implies the existence of
two interfaces, which during the simulation run fluctuate only
in the one dimension (y). The temporary position of the
interfaces can be estimated by the calculation of the rotational-
invariant order parameter18,59−63 (RIOP) for geometrical
center of molecules. The latter enables the distinction between
solid-like and liquid-like molecules because the solid-like
molecules are characterized by significantly higher values of the
order parameter. The example of obtained result for RS-
ibuprofen is presented in Figure 6b, where the calculated RIOP
for each molecule are plotted as a function of the position of
the molecule in the dimension perpendicular to the interface
plane (y direction).
The solid-like and liquid-like can be clearly distinct and the


























are the average values of the RIOP in the solid and liquid,
δ1,2 are effective widths of the interfaces, and h1,2(x) are a
functions describing the positions of the interfaces in
capillaries, i.e., sections from x to x + Δ, which are orthogonal
to the interface. During the simulation run, the h(x) describes
the interface fluctuations. The latter can be Fourier-trans-










⟨| | ⟩ = ı
(6)
where h(q) is the one-dimensional Fourier transform of h(x)
with q as the wavenumber, ⟨ ⟩ denotes the time average, kB is
Figure 6. In panel (a) the snapshot of the simulation run leading to
estimation of the IFE is shown. The two solid−liquid interfaces
positioned along the x axis are distinguished. The simulation box size
along the z axis is significantly smaller than along the x and y axis to
provide the quasi one-dimensional solid−liquid interface. The
rotational-invariant order parameter calculated along the direction
perpendicular to the solid−liquid interface is presented in panel (b).
Panel (c) shows the fluctuation spectrum of the interface height. The
dashed line is a fit of the linear function with the slope equal to −2.
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the Boltzmann constant, and Lx and Lz are width and thickness
of the simulation box. According to the CFM the interfacial
stiffness, mγ
ı, is used as a fair estimation of the γm. At this point,
it is worth mentioning that different orientations of the crystal
structure enable determination of anisotropy of γm. However,
the direct studies of model48−50,64 and realistic52,57,65,66
systems suggest that this effect is usually relatively weak, and
therefore γm can be obtained from mγ
ı determined from a single
crystallographic orientation. Then at small q, where eq 6 is
valid,48 ln(⟨|h(q)|2⟩) is a linear function of ln(q) with a slope
equals −2 and intercept which is directly related to mγ
ı. Hence
γm can be calculated by fitting the obtained dependence of ⟨|
h(q)|2⟩ on q (expressed in logarithmic scales) to the linear
function with the constant slope equal to −2 and analyzing its
intercept; see Figure 6c, where the discussed fit is presented for
RS-ibuprofen. At ambient pressure, the obtained values of γm
equal 51.1 and 67.0 mJ/m2 for S- and RS-ibuprofen,
respectively. Subsequently, the temperature dependence of


































where ΔH(T) is the enthalpy difference between the liquid
and the crystal. H(T) for both phases were obtained directly
from the computer simulation during cooling of the liquid and
heating of the crystal. Both cooling and heating have been
performed at conditions of constant temperature and pressure.
At each thermodynamic condition, the system remained for 1.5
ns (the first 0.5 ns was spared for the equilibration of the
system, whereas the data were collected in the next 1.0 ns).
After that, the temperature was changed by 10 K. Additionally,
from those computational experiments, we determined the
ρ(T) for crystal and liquid phases for both S- and RS-
ibuprofen. Simultaneously, using the well-known thermody-
namic relation, dS = dH/T (enthalpy was obtained directly
from the simulation) and based on the standard integration
method, ΔG = −∫ Tm
T ΔS dT (ΔS is a difference in the entropy
between liquid and solid states), we calculated the driving force
for crystallization. The last item necessary for calculation of the
overall crystallization rate physical quantity is the diffusion
constant. At this point, it must be noted that the time scales
accessible in standard computational experiments are too short
to obtain data for the deep supercooled state. Therefore, the
D(T) dependences obtained at analyzed isobaric conditions
have been fitted by the well-known Vogel−Fulcher−Tammann
(VFT) equation, which enables approximation of the diffusion
constant at low temperatures. The simulations D estimated
from the molecular dynamics are presented in the inset of
Figure 7. Consistent with previous reports, the dynamics of S-
and RS-ibuprofen are similar.22,68 Taking this fact into account,
we decided to fit the same VFT equation for both materials at
a given pressure. Additionally, comparison between the results
of our dielectric measurement performed for S- (see
Supporting Information) and those published for RS-
ibuprofen25,38 revealed that both systems exhibit a very similar
temperature dependence of the structural relaxation time at
constant ambient and elevated pressure.22 Finally, we
estimated the overall crystallization rate k using eqs 3, 4, and
5. The results are shown in the upper panel of Figure 7.
One can observe that the combination of CNT and the
normal model of growth does not accurately predict the
experimental k values for examined substances. However, we
would like to stress the crucial difference between the
procedure of the experiment and the simulation CNT. The
theory predicts how the liquid crystallizes during the cooling.
This concept assumes that the two components of the overall
crystallization process, i.e., the nucleation and crystal growth,
occur at different temperature ranges. The curve which
represents crystal growth is located close to the melting
temperature, whereas the nucleation is more pronounced at
lower temperatures. If both stages are separated, the system
does not crystallize because the critical nuclei are formed close
to the glass transition, at temperatures at which the crystal
growth is suppressed by insufficient molecular mobility. This
situation takes place for both S- and RS-ibuprofen, which
during cooling in the experimental study exhibits the tendency
to form a glass. Hence, to induce the crystallization and then to
study its rate, we led the substances to a temperature a little bit
lower than the glass transition temperature. This procedure
enables creation of the critical nuclei. Subsequently, we heated
the system to the temperature where crystal growth proceeds
and investigated the overall crystallization process. Taking this
fact into account and analyzing the presented theoretical
predictions given in the upper panel of Figure 7, one should
notice two crucial observations. First, the computed values of k
are smaller than the experimental. It is because the
experimentally observed crystallization rates are obtained for
Figure 7. The inset presents the diffusion constant for S- and RS-
ibuprofen at ambient and elevated pressure. The solid lines represent
the fit of the VFT equation. In the upper main panel, the solid and
dashed lines represent the overall crystallization rate predicted by the
combination of CNT and the normal model of growth at ambient and
elevated pressure. Results of an experimental examination of S- and
RS-ibuprofen are presented as points. In the lower panel, the solid and
dashed curves represent the theoretical predictions for the crystal
growth and nucleation rates, respectively.
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the crystallization process which is stimulated by the
experiment procedure, i.e., initiation of the nucleation rate at
low temperatures. The studied substances do not crystallize
during the applied cooling, and therefore one might expect that
the experimental k should be indeed smaller for the cooling
experiment. Second, the experimentally recorded crystallization
of S- and RS-ibuprofen is governed by the crystal growth rate,
and therefore it is detected closer to the melting temperature
than the theoretical expectations. In the lower panel of Figure
7 we present both N and U, and one can clearly see that the
shapes of the experimental k curves correspond well to the
theoretical U curves. Moreover, the experimentally determined
difference between overall crystallization rates at p = 0 MPa
and p = 200 MPa for RS- and S-ibuprofen correspond to
behaviors of the crystal growth rates. In this context, it is worth
noting that CNT predicts the increase in the pressure causes
the decrease in the nucleation rate for both materials.
However, the overall crystallization rate behaves differently
for RS- and S-ibuprofen, which is probably the effect of the
increase in the crystal growth rate. At given Tm − T, the gain in
U compensates for the slowdown of the nucleation, which in
the case of RS-ibuprofen results in the theoretically predicted
increase in the crystallization tendency.
At this point, we should also comment on the fact that on
the basis of the result presented in Figure 1 one can conclude
that RS-ibuprofen exhibits a higher crystallization tendency
(the racemic mixture crystallizes during the heating), whereas k
values presented in upper panel of Figure 7 are smaller for this
substance. Typically, it is considered that both quantities are
coupled, and consequently the theoretically predicted k should
be higher for RS-ibuprofen. However, our results revealed
differences, which might be due to different experimental
procedures. As we already mentioned, in studied cases, i.e.,
when crystallization is triggered by prior cooling of the system
up to Tg, the overall crystallization rate is mainly governed by
U. In this context, it is worth noting that in Figure 1 RS-
ibuprofen crystallizes about 40 K below Tm. Interestingly, at
corresponding temperatures, i.e., at T > Tm − 40, U for RS-
ibuprofen is higher than for pure S-enantiomer; see lower panel
of Figure 7. Hence, we can suspect that during calorimetric
experiments U for S-ibuprofen is not sufficient to progress the
crystallization of the system, especially during the applied
heating rate. It is because during fast heating the nucleation is
strongly limited, and consequently the role of crystal growth in
crystallization increases. However, when the heating from glass
to desire temperature is slower, like took place during dielectric
measurements, the role of nucleation is less suppressed.
Consequently, participation of N, which exhibits higher values
for S-ibuprofen, in the overall crystallization process becomes
more effective, and then we observe the higher k values for S-
ibuprofen. Hence, the presented results put attention on the
interesting aspect of the crystallization studies, which is the
connection between the heating rate and the system stability
behavior.
Nevertheless, combining upper and lower panels of Figure 7,
we can state that the combination of CNT and the normal
model of growth qualitatively predicts differences in the rate of
the crystallization process, which are experimentally observed
for RS- and S-ibuprofen; i.e., at ambient pressure, S-ibuprofen
crystallizes faster than the racemic mixture. Hence, CNT could
be used to investigate the reason for the faster crystallization of
pure S-ibuprofen. In this context, we would like to recall that
the dynamics of the two studied systems are almost identical.
Therefore, thermodynamic aspects of the crystallization
process should be examined in detail.22,68 Consequently, in
Figure 8 we present ΔG and γ for both substances.
As one can observe, at ambient pressure, ΔG and γ are
higher for RS-ibuprofen than for the pure S-enantiomer at all
temperatures. On the basis of the expression of the nucleation
barrier ΔG* (see eq 4), a higher driving force ΔG facilitates
nucleation. Oppositely, a higher γ makes the creation of the
solid−liquid interface more costly in free energy and so does
not favor nucleation. It thus seems that the contribution of γ
dominates in the crystallization trend between RS- and S-
ibuprofen. The mutual relationship between both discussed






Δ * = π γΔ υ ) for S-ibuprofen (results not presented).
During compression, both materials present similar trends
for ΔG; see Figure 8. Interestingly, as we present in the inset of
Figure 8, the pressure dependence of γm and thus γ (see eq 7)
is entirely different for two materials; i.e., the increase in the
pressure implies an increase in the γm and then an impediment
of the crystallization for S-ibuprofen, whereas for racemic
mixture γm decreases during compression. To confirm this
observation, we used the CFM to calculate γm at 400 MPa; see
inset in Figure 8. The obtained results are in agreement with
the trend recorded experimentally from 0 to 200 MPa; i.e.,
when pressure increases, the crystallization process slows down
more significantly in the case of the S-enantiomer. Hence, we
can state that the γ is the main factor leading to observed
differences in the crystallization rates for S- and RS-ibuprofen.
In this context, it has to be stressed that, in the presented
study, we have not been able to experimentally examine the
crystallization process kinetics at 400 MPa due to the limits of
the equipment used.
The fact that γm for RS-ibuprofen is higher than that for pure
S-enantiomer could be naturally explained by the fact that both
materials crystallize to different space groups, i.e., P21/c for RS-
ibuprofen and P21 for S-ibuprofen.
24 Thus, naturally we might
expect different values of the solid−liquid interfacial free
energy at given melting conditions. Moreover, their temper-
ature−pressure dependences of γm would also be different.
Nevertheless, it must be noted that in most cases the racemic
Figure 8. Temperature dependence of the driving force for the
crystallization process and the solid−liquid interfacial free energy
calculated for RS- and S-ibuprofen at ambient and elevated pressure.
The inset presents the value of the solid−liquid interfacial free energy
as a function of pressure.
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solid compounds are often marginally stable over the
enantiopure forms.69,70 This trend is well in line with the
density of the crystal form of RS-ibuprofen ρRS = 1.12 g/cm3,71
which is slightly above the density of S-ibuprofen ρS = 1.09 g/
cm3.72 Assuming that the liquid forms of RS- and S-ibuprofen
are similar (they possess similar mobility, Tg, etc.), one can
thus expect that the more ordered crystalline RS-ibuprofen
form shows a larger difference with its liquid state than the S-
ibuprofen, and consequently γm
RS > γm
S . Additionally, it is worth
noting that the liquid of RS-ibuprofen is intrinsically more
disordered than S-ibuprofen because of the R and S mixture.
This enantiomeric disorder does not seem to impact the
dynamics; however, there is a difference in the entropy
between RS and S, which as well means that γm
RS > γm
S . We
would like to also mention that recent studies pointed out that
R- and S-ibuprofen could persist in anti- as well as syn-
periplanar conformation.24 The latter implies that to form the
solid−liquid interface, the molecules have to undergo anti- to
syn-transition because crystal structures of S- and RS-ibuprofen
are comprised solely from molecules exhibiting syn-periplanar
conformation. Hence, the interface’s formation requires
additional work related to the transition from anti- to syn-
conformation. Importantly, the recent results report that at
ambient pressure and at a given temperature, the number of
molecules characterized by the antiperiplanar conformation is
higher for the racemic mixture.24 Consequently, the energy
needed to form the interface is higher, and therefore one can
expect the higher value of γm for RS-ibuprofen.
In the case of the pressure dependence of γm, it should be
recalled that despite its importance in the physical description
of the crystal morphology or the nucleation rate, only a few
experimental data of γ are actually available in the literature
and mostly for metallic alloys. Data for molecular compounds
are even scarcer.73−75 To the authors’ knowledge, no
experimental data on the pressure dependence of the solid−
liquid interfacial energy exist, and only a few numerical works
have been performed mostly on Lennard-Jones simple atomic
systems and water.76−78 From these simulations, it seems that
the solid−liquid interfacial free energy γm increases along the
coexistence line; i.e., γm increases upon increasing pressure or
temperature as observed for S-ibuprofen in the present study.
Nevertheless, to examine in detail and then to understand the
effect of the compression on the solid−liquid interfacial free
energy, additional work has to be performed.
Finally, it seems to be interesting to compare the obtained
values of γm for S- and RS-ibuprofen with some other values
reported for pharmaceutical substances such as nifedipine
(21.5 and 14.4 mJ/m2 for α and β polymorphic form
respectively), felodipine (28.7 and 15.5 for I and II form
respectively), and indomethacin (22 and 27 mJ/m2 for Iα and
IIγ form respectively). One can notice that both forms of
ibuprofen are characterized by values of γm, which are about
two times higher than for other mentioned substances. It
implies that the nucleation rate of ibuprofen would be expected
to be relatively low, and hence vitrification of this drug is
facilitated.
Summarizing, in this paper, we examined in detail the
crystallization process for the S-enantiomer and the racemic
mixture of ibuprofen at ambient and elevated pressures.
Experimental studies revealed that the S-enantiomer crystal-
lizes faster than the racemic mixture at ambient pressure
conditions. Employing the CNT and the normal model of the
crystal growth, we predict that the increase in the pressure
means that the crystallization of the S-enantiomer slows down,
whereas it accelerates for a racemic mixture. Taking into
account that both studied systems are characterized by almost
identical molecular mobility, the thermodynamic aspect of the
crystallization process should be responsible for the observed
differences in the crystallization rate. The results of the
performed computational studies show that at ambient
pressure γm for S-ibuprofen is smaller than for the racemic
mixture. Additionally, we present that when the pressure
increases γm behaves entirely differently for S- and RS-
ibuprofen. In the case of the racemic mixture γm decreases,
whereas for the S-enantiomer it increases, which corresponds
to the behavior of the overall crystallization rate. Hence, taking
into account that the diffusion and driving force, i.e., the other
factors influencing the rate of the formation of the nuclei
within the liquid, exhibit very similar changes during
compression, the solid−liquid interfacial free energy variations
should be considered as the main factor responsible for the
theoretically predicted behavior of the crystallization process.
This observation seems to be even more intriguing if one
considers that γm hypothetically might be sensitive not only for
the crystal structure formed but also for the composition of
different conformations within the liquid system. The latter
implies that the appropriate molecular composition might be
used for the practical management of the crystallization
process. Hence, from the presented study, we suggest new
ways leading to the control of the stability behavior of
materials below the melting temperature, which is extremely
advantageous in the case of poorly water-soluble and therefore
slightly bioavailable crystalline pharmaceuticals.
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(11) Hasselalatt, M. Über Den Einfluß Des Druckes Auf Das
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